2025-2026 Regular SessionNew York Legislature

S00371

Legislative Summary

Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.

Demographic Impact

Overall analysis of equity impact

80% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

1/8/2025
REFERRED TO HEALTH
Senate
1/21/2025
REPORTED AND COMMITTED TO FINANCE
Senate
3/11/2025
1ST REPORT CAL.523
Senate
3/12/2025
2ND REPORT CAL.
Senate
3/13/2025
ADVANCED TO THIRD READING
Senate
5/20/2025
PASSED SENATE
Senate
5/20/2025
DELIVERED TO ASSEMBLY
Senate
5/20/2025
referred to higher education
Assembly

Roll Call Votes

Senate Floor Vote - Final Passage
5/20/2025
56
Yea
5
Nay
0
Not Voting
1
Absent
Result: PASSED
Senate Finance Committee Vote
3/11/2025
20
Yea
1
Nay
0
Not Voting
1
Absent
Result: PASSED
Senate Health Committee Vote
1/21/2025
14
Yea
0
Nay
0
Not Voting
1
Absent
Result: PASSED

Status Information

Current Status
Engrossed(5/20/2025)
Chamber
Assembly
Committee
Higher Education(Assembly)

Sponsors

Democrat: 2

Primary Sponsor

James Skoufis
James Skoufis
Democrat

Co-Sponsors (1)

Documents

Introduced
Bill Text1/8/202512.0 KB